* In 2 placebo-controlled SAR studies (N=1143), ASTEPRO 0.15% (2 sprays per nostril) relieved allergic rhinitis symptoms as early as 30 to 45 minutes, and the effect remained durable over the 4-hour assessment period.
† When prescribed once daily for SAR; calculation based on 2 sprays per nostril once daily.
ASTEPRO® (azelastine HCl) Nasal Spray 0.15% is indicated for the relief of the symptoms of seasonal and perennial allergic rhinitis in patients 12 years of age and older.
© 2012 Meda Pharmaceuticals Inc. All rights reserved. AST-12-0004